Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic Approaches to Understanding Response and Resistance to Immunotherapy.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Dec 2016

Braun David A, Burke Kelly P, Van Allen Eliezer M

Abstract excerpt

Immunotherapy has led to a paradigm shift in the treatment of some malignancies, providing long-term, durable responses for patients with advanced cancers. However, such therapy has benefited only a subset of patients, with some patients failing to respond to treatment at all and others achieving a limited response followed by tumor progression. Understanding factors contributing to an effective response and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to PTEN gene

Share to Genomics

Share to Immunotherapy

Share to Mutation

Share to Neoplasms

Share to Transcriptome

Source

Open in PubMed Open full text

Identifiers

PMID: 27698000
DOI: 10.1158/1078-0432.CCR-16-0066
PMCID: PMC5135569

Genes

PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic Approaches to Understanding Response and Resistance to Immunotherapy.PMID 27698000Read ↗

Molecular and Genomic Determinants of Response to Immune Checkpoint Inhibition in CancerSemantic proximity Read ↗

Mutational Landscape and Sensitivity to Immune Checkpoint Blockers.Semantic proximity Read ↗

Genomics of response to immune checkpoint therapies for cancer: implications for precision medicineSemantic proximity Read ↗

Navigating the Immune Maze: Pioneering Strategies for Un-shackling Cancer Immunotherapy ResistanceSemantic proximity Read ↗

Genetic Dysregulation of Immunologic and Oncogenic Signaling Pathways Associated with Tumor-intrinsic Immune Resistance: A Molecular Basis for Combination Targeted Therapy-Immunotherapy for CancerSemantic proximity Read ↗

Predicting immunotherapy response through genomicsSemantic proximity Read ↗

Phenotypic Plasticity, Non-genetic Mechanisms, and Immune Drug Resistance in Cancer.Semantic proximity Read ↗

Whole-genome sequencing uncovers the genomic determinants of therapeutic resistance to immune checkpoint blockadeSemantic proximity Read ↗

Gene-expression profiling to predict responsiveness to immunotherapy.Semantic proximity Read ↗

Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma.Semantic proximity Read ↗

Personalized immunotherapy in cancer precision medicineSemantic proximity Read ↗

Is tumor mutational burden predictive of response to immunotherapy?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.